Toppgene analysis for Wikipedia protein communities, toppgene analysis, cc181_12, positive side

Go To Start Page
Input Parameters [Show Detail]
Training Results [Expand All] [Download All] [Sparse Matrix]
Display pValues and Scores as Table row limit

1: GO: Molecular Function [Display Chart] 12 input genes in category / 42 annotations before applied cutoff / 18661 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0000982 transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding 9.179E-12 3.855E-10 1.668E-9 3.855E-10 8 365
2 GO:0000978 RNA polymerase II proximal promoter sequence-specific DNA binding 9.789E-10 1.926E-8 8.335E-8 4.111E-8 7 379
3 GO:0000987 proximal promoter sequence-specific DNA binding 1.376E-9 1.926E-8 8.335E-8 5.779E-8 7 398
4 GO:0001077 proximal promoter DNA-binding transcription activator activity, RNA polymerase II-specific 5.813E-9 6.104E-8 2.641E-7 2.442E-7 6 259
5 GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific 3.942E-8 3.311E-7 1.433E-6 1.656E-6 6 357
6 GO:0035400 histone tyrosine kinase activity 6.431E-4 3.858E-3 1.669E-2 2.701E-2 1 1
7 GO:0035401 histone kinase activity (H3-Y41 specific) 6.431E-4 3.858E-3 1.669E-2 2.701E-2 1 1
8 GO:0032422 purine-rich negative regulatory element binding 1.928E-3 1.012E-2 4.380E-2
8.098E-2
 1 3
9 GO:0005143 interleukin-12 receptor binding 3.211E-3 1.499E-2
6.484E-2
1.349E-1
 1 5
10 GO:0005131 growth hormone receptor binding 3.853E-3 1.618E-2
7.001E-2
1.618E-1
 1 6
11 GO:0001227 DNA-binding transcription repressor activity, RNA polymerase II-specific 5.855E-3 1.924E-2
8.325E-2
2.459E-1
 2 182
12 GO:0051427 hormone receptor binding 5.918E-3 1.924E-2
8.325E-2
2.485E-1
 2 183
13 GO:0033130 acetylcholine receptor binding 6.413E-3 1.924E-2
8.325E-2
2.694E-1
 1 10
14 GO:0031702 type 1 angiotensin receptor binding 6.413E-3 1.924E-2
8.325E-2
2.694E-1
 1 10
15 GO:0043560 insulin receptor substrate binding 7.692E-3 2.019E-2
8.736E-2
3.230E-1
 1 12
16 GO:0031701 angiotensin receptor binding 7.692E-3 2.019E-2
8.736E-2
3.230E-1
 1 12
17 GO:0051428 peptide hormone receptor binding 1.088E-2 2.687E-2
1.162E-1
4.570E-1
 1 17
18 GO:0035173 histone kinase activity 1.215E-2 2.687E-2
1.162E-1
5.104E-1
 1 19
19 GO:0035259 glucocorticoid receptor binding 1.215E-2 2.687E-2
1.162E-1
5.104E-1
 1 19
20 GO:0035035 histone acetyltransferase binding 1.913E-2 4.017E-2
1.738E-1
8.034E-1
 1 30
21 GO:0042169 SH2 domain binding 2.165E-2 4.330E-2
1.874E-1
9.094E-1
 1 34
22 GO:0043548 phosphatidylinositol 3-kinase binding 2.417E-2 4.615E-2
1.997E-1
1.000E0
 1 38
Show 17 more annotations

2: GO: Biological Process [Display Chart] 12 input genes in category / 443 annotations before applied cutoff / 18623 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0030099 myeloid cell differentiation 2.686E-6 1.190E-3 7.939E-3 1.190E-3 5 388
2 GO:0046677 response to antibiotic 4.769E-4 4.758E-2
3.174E-1
2.112E-1
 2 51
3 GO:0030219 megakaryocyte differentiation 5.150E-4 4.758E-2
3.174E-1
2.282E-1
 2 53
4 GO:0034050 host programmed cell death induced by symbiont 6.444E-4 4.758E-2
3.174E-1
2.855E-1
 1 1
5 GO:0035409 histone H3-Y41 phosphorylation 6.444E-4 4.758E-2
3.174E-1
2.855E-1
 1 1
6 GO:0035406 histone-tyrosine phosphorylation 6.444E-4 4.758E-2
3.174E-1
2.855E-1
 1 1
Show 1 more annotation

3: GO: Cellular Component [Display Chart] 12 input genes in category / 17 annotations before applied cutoff / 19061 genes in category

No results to display

4: Human Phenotype [Display Chart] 6 input genes in category / 724 annotations before applied cutoff / 4707 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 HP:0011846 Osteoblastoma 7.325E-10 5.304E-7 3.799E-6 5.304E-7 4 14
2 HP:0100246 Osteoma 2.236E-9 5.662E-7 4.056E-6 1.619E-6 4 18
3 HP:0002896 Neoplasm of the liver 2.346E-9 5.662E-7 4.056E-6 1.699E-6 6 174
4 HP:0010762 Chordoma 9.223E-9 1.666E-6 1.193E-5 6.677E-6 4 25
5 HP:0006717 Peripheral neuroepithelioma 1.150E-8 1.666E-6 1.193E-5 8.328E-6 3 5
6 HP:0100243 Leiomyosarcoma 1.878E-8 2.154E-6 1.543E-5 1.360E-5 5 96
7 HP:0012254 Ewing sarcoma 2.299E-8 2.154E-6 1.543E-5 1.665E-5 3 6
8 HP:0006743 Embryonal rhabdomyosarcoma 2.615E-8 2.154E-6 1.543E-5 1.894E-5 4 32
9 HP:0006741 Increased risk of malignancy 2.975E-8 2.154E-6 1.543E-5 2.154E-5 4 33
10 HP:0006765 Chondrosarcoma 2.975E-8 2.154E-6 1.543E-5 2.154E-5 4 33
11 HP:0100244 Fibrosarcoma 7.343E-8 4.833E-6 3.462E-5 5.316E-5 4 41
12 HP:0006721 Acute lymphoblastic leukemia 1.271E-7 7.668E-6 5.492E-5 9.201E-5 5 140
13 HP:0007378 Neoplasm of the gastrointestinal tract 2.025E-7 1.128E-5 8.076E-5 1.466E-4 6 363
14 HP:0004808 Acute myeloid leukemia 2.491E-7 1.288E-5 9.229E-5 1.804E-4 5 160
15 HP:0001945 Fever 1.178E-6 5.450E-5 3.904E-4 8.531E-4 6 486
16 HP:0002488 Acute leukemia 1.205E-6 5.450E-5 3.904E-4 8.721E-4 5 219
17 HP:0006779 Alveolar rhabdomyosarcoma 1.302E-6 5.545E-5 3.972E-4 9.426E-4 3 20
18 HP:0002859 Rhabdomyosarcoma 1.991E-6 7.311E-5 5.237E-4 1.441E-3 4 92
19 HP:0002669 Osteosarcoma 1.991E-6 7.311E-5 5.237E-4 1.441E-3 4 92
20 HP:0009734 Optic nerve glioma 2.020E-6 7.311E-5 5.237E-4 1.462E-3 3 23
21 HP:0002907 Microscopic hematuria 2.307E-6 7.954E-5 5.697E-4 1.670E-3 3 24
22 HP:0009728 Neoplasm of striated muscle 2.676E-6 8.805E-5 6.307E-4 1.937E-3 4 99
23 HP:0008663 Renal sarcoma 2.961E-6 9.320E-5 6.676E-4 2.144E-3 3 26
24 HP:0002202 Pleural effusion 3.243E-6 9.782E-5 7.007E-4 2.348E-3 5 267
25 HP:0009733 Glioma 3.522E-6 1.020E-4 7.307E-4 2.550E-3 4 106
26 HP:0002888 Ependymoma 3.727E-6 1.038E-4 7.434E-4 2.698E-3 3 28
27 HP:0002103 Abnormality of the pleura 4.258E-6 1.142E-4 8.179E-4 3.083E-3 5 282
28 HP:0011794 Embryonal renal neoplasm 5.059E-6 1.308E-4 9.370E-4 3.663E-3 4 116
29 HP:0002835 Aspiration 5.892E-6 1.471E-4 1.054E-3 4.266E-3 5 301
30 HP:0001875 Neutropenia 8.498E-6 2.046E-4 1.466E-3 6.153E-3 5 324
31 HP:0011991 Abnormal neutrophil count 8.762E-6 2.046E-4 1.466E-3 6.344E-3 5 326
32 HP:0030450 Neuroplasm of the autonomic nervous system 1.034E-5 2.269E-4 1.625E-3 7.488E-3 3 39
33 HP:0003005 Ganglioneuroma 1.034E-5 2.269E-4 1.625E-3 7.488E-3 3 39
34 HP:0002665 Lymphoma 1.161E-5 2.472E-4 1.771E-3 8.405E-3 5 345
35 HP:0030448 Soft tissue sarcoma 1.212E-5 2.507E-4 1.796E-3 8.774E-3 5 348
36 HP:0012062 Bone cyst 1.601E-5 3.220E-4 2.307E-3 1.159E-2 3 45
37 HP:0100526 Neoplasm of the lung 1.830E-5 3.580E-4 2.565E-3 1.325E-2 4 160
38 HP:0100606 Neoplasm of the respiratory system 2.068E-5 3.940E-4 2.822E-3 1.497E-2 4 165
39 HP:0001874 Abnormality of neutrophils 2.159E-5 4.009E-4 2.871E-3 1.563E-2 5 391
40 HP:0003109 Hyperphosphaturia 2.485E-5 4.499E-4 3.222E-3 1.799E-2 3 52
41 HP:0002861 Melanoma 2.555E-5 4.511E-4 3.231E-3 1.849E-2 4 174
42 HP:0010622 Neoplasm of the skeletal system 3.054E-5 5.180E-4 3.710E-3 2.211E-2 4 182
43 HP:0100242 Sarcoma 3.076E-5 5.180E-4 3.710E-3 2.227E-2 5 420
44 HP:0012599 Abnormal urine phosphate concentration 3.644E-5 5.700E-4 4.083E-3 2.638E-2 3 59
45 HP:0009919 Retinoblastoma 3.698E-5 5.700E-4 4.083E-3 2.678E-2 4 191
46 HP:0012777 Retinal neoplasm 3.698E-5 5.700E-4 4.083E-3 2.678E-2 4 191
47 HP:0012150 Single lineage myelodysplasia 3.779E-5 5.700E-4 4.083E-3 2.736E-2 2 8
48 HP:0004828 Refractory anemia with ringed sideroblasts 3.779E-5 5.700E-4 4.083E-3 2.736E-2 2 8
49 HP:0001909 Leukemia 4.094E-5 6.048E-4 4.332E-3 2.964E-2 5 445
50 HP:0003006 Neuroblastoma 4.351E-5 6.177E-4 4.425E-3 3.150E-2 4 199
Show 45 more annotations

5: Mouse Phenotype [Display Chart] 12 input genes in category / 504 annotations before applied cutoff / 10355 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 MP:0011099 lethality throughout fetal growth and development, complete penetrance 8.009E-7 4.036E-4 2.745E-3 4.036E-4 6 331
2 MP:0011091 prenatal lethality, complete penetrance 2.572E-6 6.482E-4 4.408E-3 1.296E-3 6 404
3 MP:0000229 abnormal megakaryocyte differentiation 5.249E-6 7.436E-4 5.057E-3 2.645E-3 3 31
4 MP:0005017 decreased B cell number 7.344E-6 7.436E-4 5.057E-3 3.701E-3 6 484
5 MP:0000988 abnormal pacinian corpuscle morphology 7.377E-6 7.436E-4 5.057E-3 3.718E-3 2 4
6 MP:0004938 dilated vasculature 1.642E-5 1.326E-3 9.019E-3 8.275E-3 3 45
7 MP:0020321 increased vascular endothelial cell apoptosis 1.842E-5 1.326E-3 9.019E-3 9.284E-3 2 6
8 MP:0000973 abnormal cutaneous/subcutaneous mechanoreceptor morphology 2.577E-5 1.443E-3 9.815E-3 1.299E-2 2 7
9 MP:0020320 abnormal vascular endothelial cell apoptosis 2.577E-5 1.443E-3 9.815E-3 1.299E-2 2 7
10 MP:0000715 decreased thymocyte number 4.457E-5 2.247E-3 1.528E-2 2.247E-2 4 186
11 MP:0008486 decreased muscle spindle number 1.282E-4 5.874E-3 3.995E-2
6.461E-2
 2 15
12 MP:0013554 abnormal apocrine gland morphology 1.545E-4 5.970E-3 4.060E-2
7.785E-2
 4 256
13 MP:0000627 abnormal mammary gland morphology 1.545E-4 5.970E-3 4.060E-2
7.785E-2
 4 256
14 MP:0004297 abnormal proprioceptive neuron morphology 1.658E-4 5.970E-3 4.060E-2
8.358E-2
 2 17
15 MP:0010299 increased mammary gland tumor incidence 1.859E-4 6.246E-3 4.248E-2
9.369E-2
 3 101
16 MP:0000990 abnormal skeletal muscle mechanoreceptor morphology 2.312E-4 6.701E-3 4.557E-2
1.165E-1
 2 20
17 MP:0004069 abnormal muscle spindle morphology 2.312E-4 6.701E-3 4.557E-2
1.165E-1
 2 20
18 MP:0002417 abnormal megakaryocyte morphology 2.393E-4 6.701E-3 4.557E-2
1.206E-1
 3 110
19 MP:0005093 decreased B cell proliferation 2.659E-4 7.055E-3 4.798E-2
1.340E-1
 3 114
20 MP:0013660 abnormal bone marrow hematopoietic cell morphology 3.018E-4 7.425E-3
5.050E-2
1.521E-1
 3 119
21 MP:0008801 abnormal erythroid progenitor cell morphology 3.094E-4 7.425E-3
5.050E-2
1.559E-1
 3 120
22 MP:0002144 abnormal B cell differentiation 4.955E-4 1.135E-2
7.720E-2
2.497E-1
 4 347
23 MP:0000245 abnormal erythropoiesis 5.726E-4 1.255E-2
8.533E-2
2.886E-1
 3 148
24 MP:0001601 abnormal myelopoiesis 7.059E-4 1.482E-2
1.008E-1
3.558E-1
 3 159
25 MP:0010293 increased integument system tumor incidence 8.144E-4 1.642E-2
1.117E-1
4.104E-1
 3 167
26 MP:0013662 decreased myeloid cell number 9.827E-4 1.718E-2
1.168E-1
4.953E-1
 4 416
27 MP:0000249 abnormal blood vessel physiology 1.028E-3 1.718E-2
1.168E-1
5.180E-1
 4 421
28 MP:0005153 abnormal B cell proliferation 1.062E-3 1.718E-2
1.168E-1
5.353E-1
 3 183
29 MP:0003227 abnormal vascular branching morphogenesis 1.083E-3 1.718E-2
1.168E-1
5.457E-1
 2 43
30 MP:0003135 increased erythroid progenitor cell number 1.083E-3 1.718E-2
1.168E-1
5.457E-1
 2 43
31 MP:0002261 abnormal laryngeal mucosa morphology 1.159E-3 1.718E-2
1.168E-1
5.841E-1
 1 1
32 MP:0002369 abnormal thymus subcapsular epithelium morphology 1.159E-3 1.718E-2
1.168E-1
5.841E-1
 1 1
33 MP:0010790 abnormal stomach pyloric antrum morphology 1.159E-3 1.718E-2
1.168E-1
5.841E-1
 1 1
34 MP:0002241 abnormal laryngeal mucosa goblet cell morphology 1.159E-3 1.718E-2
1.168E-1
5.841E-1
 1 1
35 MP:0008782 increased B cell apoptosis 1.293E-3 1.815E-2
1.235E-1
6.516E-1
 2 47
36 MP:0011092 embryonic lethality, complete penetrance 1.329E-3 1.815E-2
1.235E-1
6.700E-1
 4 451
37 MP:0008217 abnormal B cell activation 1.353E-3 1.815E-2
1.235E-1
6.820E-1
 3 199
38 MP:0000208 decreased hematocrit 1.393E-3 1.815E-2
1.235E-1
7.020E-1
 3 201
39 MP:0001052 abnormal innervation pattern to muscle 1.405E-3 1.815E-2
1.235E-1
7.080E-1
 2 49
40 MP:0010373 myeloid hyperplasia 1.521E-3 1.916E-2
1.303E-1
7.666E-1
 2 51
41 MP:0001718 abnormal visceral yolk sac morphology 2.077E-3 2.335E-2
1.588E-1
1.000E0
 3 231
42 MP:0004003 abnormal vascular endothelial cell physiology 2.099E-3 2.335E-2
1.588E-1
1.000E0
 2 60
43 MP:0008826 abnormal splenic cell ratio 2.312E-3 2.335E-2
1.588E-1
1.000E0
 2 63
44 MP:0003903 increased cell mass 2.316E-3 2.335E-2
1.588E-1
1.000E0
 1 2
45 MP:0000999 abnormal golgi tendon organ morphology 2.316E-3 2.335E-2
1.588E-1
1.000E0
 1 2
46 MP:0000406 increased curvature of auchene hairs 2.316E-3 2.335E-2
1.588E-1
1.000E0
 1 2
47 MP:0000403 increased curvature of zigzag hairs 2.316E-3 2.335E-2
1.588E-1
1.000E0
 1 2
48 MP:0001000 absent golgi tendon organ 2.316E-3 2.335E-2
1.588E-1
1.000E0
 1 2
49 MP:0010863 absent respiratory mucosa goblet cells 2.316E-3 2.335E-2
1.588E-1
1.000E0
 1 2
50 MP:0010820 abnormal pleura morphology 2.316E-3 2.335E-2
1.588E-1
1.000E0
 1 2
Show 45 more annotations

6: Domain [Display Chart] 12 input genes in category / 48 annotations before applied cutoff / 18735 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 PS00345 ETS DOMAIN 1 PROSITE 1.033E-31 8.262E-31 3.684E-30 4.957E-30 11 28
2 IPR000418 Ets dom InterPro 1.033E-31 8.262E-31 3.684E-30 4.957E-30 11 28
3 SM00413 ETS SMART 1.033E-31 8.262E-31 3.684E-30 4.957E-30 11 28
4 PS00346 ETS DOMAIN 2 PROSITE 1.033E-31 8.262E-31 3.684E-30 4.957E-30 11 28
5 PF00178 Ets Pfam 1.033E-31 8.262E-31 3.684E-30 4.957E-30 11 28
6 PS50061 ETS DOMAIN 3 PROSITE 1.033E-31 8.262E-31 3.684E-30 4.957E-30 11 28
7 1.10.10.10 - Gene3D 4.881E-21 3.347E-20 1.492E-19 2.343E-19 11 218
8 IPR011991 WHTH DNA-bd dom InterPro 1.653E-20 9.917E-20 4.422E-19 7.934E-19 11 243
9 PS51433 PNT PROSITE 7.104E-18 2.841E-17 1.267E-16 3.410E-16 6 11
10 PF02198 SAM PNT Pfam 7.104E-18 2.841E-17 1.267E-16 3.410E-16 6 11
11 IPR003118 Pointed dom InterPro 7.104E-18 2.841E-17 1.267E-16 3.410E-16 6 11
12 SM00251 SAM PNT SMART 7.104E-18 2.841E-17 1.267E-16 3.410E-16 6 11
13 1.10.150.50 - Gene3D 2.555E-11 9.435E-11 4.207E-10 1.227E-9 6 106
14 IPR013761 SAM/pointed InterPro 4.671E-11 1.601E-10 7.140E-10 2.242E-9 6 117
15 IPR016311 Transform prot C-ets InterPro 3.761E-7 1.203E-6 5.366E-6 1.805E-5 2 2
16 PF04621 ETS PEA3 N Pfam 1.128E-6 3.185E-6 1.420E-5 5.414E-5 2 3
17 IPR006715 ETS PEA3 N InterPro 1.128E-6 3.185E-6 1.420E-5 5.414E-5 2 3
18 IPR020693 Tyr kinase non-rcpt Jak2 InterPro 6.405E-4 1.337E-3 5.960E-3 3.074E-2 1 1
19 IPR032928 ETS V1 InterPro 6.405E-4 1.337E-3 5.960E-3 3.074E-2 1 1
20 PF11620 GABP-alpha Pfam 6.405E-4 1.337E-3 5.960E-3 3.074E-2 1 1
21 IPR024668 GABP asu N InterPro 6.405E-4 1.337E-3 5.960E-3 3.074E-2 1 1
22 IPR027276 Transform prot C-ets-2 InterPro 6.405E-4 1.337E-3 5.960E-3 3.074E-2 1 1
23 IPR016312 TF GA-bd asu InterPro 6.405E-4 1.337E-3 5.960E-3 3.074E-2 1 1
24 IPR016251 Tyr kinase non-rcpt Jak/Tyk2 InterPro 2.560E-3 5.120E-3 2.283E-2
1.229E-1
 1 4
25 IPR019748 FERM central InterPro 3.095E-2 4.888E-2
2.179E-1
1.000E0
 1 49
26 IPR000299 FERM domain InterPro 3.095E-2 4.888E-2
2.179E-1
1.000E0
 1 49
27 PS00661 FERM 2 PROSITE 3.157E-2 4.888E-2
2.179E-1
1.000E0
 1 50
28 IPR019749 Band 41 domain InterPro 3.157E-2 4.888E-2
2.179E-1
1.000E0
 1 50
29 SM00295 B41 SMART 3.157E-2 4.888E-2
2.179E-1
1.000E0
 1 50
30 PS00660 FERM 1 PROSITE 3.157E-2 4.888E-2
2.179E-1
1.000E0
 1 50
31 PS50057 FERM 3 PROSITE 3.157E-2 4.888E-2
2.179E-1
1.000E0
 1 50
Show 26 more annotations

7: Pathway [Display Chart] 12 input genes in category / 158 annotations before applied cutoff / 12450 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 P00047 PDGF signaling pathway PantherDB 8.793E-10 1.389E-7 7.840E-7 1.389E-7 6 127
2 523016 Transcriptional misregulation in cancer BioSystems: KEGG 4.360E-7 3.444E-5 1.944E-4 6.888E-5 5 180
3 114227 Dorso-ventral axis formation BioSystems: KEGG 2.211E-6 1.165E-4 6.572E-4 3.494E-4 3 28
4 P00036 Interleukin signaling pathway PantherDB 8.187E-5 3.234E-3 1.825E-2 1.293E-2 3 92
5 M14449 METS affect on Macrophage Differentiation MSigDB C2 BIOCARTA (v6.0) 1.292E-4 4.083E-3 2.304E-2 2.041E-2 2 18
6 1270427 Oncogene Induced Senescence BioSystems: REACTOME 4.157E-4 1.095E-2
6.177E-2
6.568E-2
 2 32
7 M19118 Keratinocyte Differentiation MSigDB C2 BIOCARTA (v6.0) 8.609E-4 1.692E-2
9.548E-2
1.360E-1
 2 46
8 PW:0000568 aldosterone signaling Pathway Ontology 9.639E-4 1.692E-2
9.548E-2
1.523E-1
 1 1
9 PW:0000297 platelet-derived growth factor signaling Pathway Ontology 9.639E-4 1.692E-2
9.548E-2
1.523E-1
 1 1
10 137933 IL4-mediated signaling events BioSystems: Pathway Interaction Database 1.610E-3 2.366E-2
1.335E-1
2.544E-1
 2 63
11 373901 HTLV-I infection BioSystems: KEGG 1.647E-3 2.366E-2
1.335E-1
2.603E-1
 3 256
12 PW:0000367 altered JAK-STAT signaling Pathway Ontology 1.927E-3 2.537E-2
1.432E-1
3.044E-1
 1 2
13 138073 C-MYB transcription factor network BioSystems: Pathway Interaction Database 2.456E-3 2.984E-2
1.684E-1
3.880E-1
 2 78
Show 8 more annotations

8: Pubmed [Display Chart] 12 input genes in category / 3754 annotations before applied cutoff / 38193 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 17907201 ETS-family genes in pancreatic development. Pubmed 4.082E-35 1.532E-31 1.350E-30 1.532E-31 11 28
2 22056786 ETS-dependent regulation of a distal Gata4 cardiac enhancer. Pubmed 4.151E-32 7.792E-29 6.863E-28 1.558E-28 10 23
3 26097038 Articular cartilage endurance and resistance to osteoarthritic changes require transcription factor Erg. Pubmed 2.163E-27 2.707E-24 2.384E-23 8.120E-24 9 27
4 14635793 Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis. Pubmed 1.324E-26 1.243E-23 1.094E-22 4.970E-23 8 14
5 20932939 Screening large numbers of expression patterns of transcription factors in late stages of the mouse thymus. Pubmed 3.185E-18 2.391E-15 2.106E-14 1.196E-14 9 243
6 25802403 Induction of hematopoietic and endothelial cell program orchestrated by ETS transcription factor ER71/ETV2. Pubmed 1.504E-15 9.408E-13 8.286E-12 5.645E-12 5 13
7 22340503 Opposing functions of the ETS factor family define Shh spatial expression in limb buds and underlie polydactyly. Pubmed 1.953E-13 1.048E-10 9.227E-10 7.333E-10 4 7
8 9681824 Erg proteins, transcription factors of the Ets family, form homo, heterodimers and ternary complexes via two distinct domains. Pubmed 3.906E-13 1.833E-10 1.614E-9 1.466E-9 4 8
9 20610757 Expression of dopamine pathway genes in the midbrain is independent of known ETS transcription factor activity. Pubmed 1.841E-12 7.677E-10 6.762E-9 6.910E-9 4 11
10 24727028 Fli1 acts downstream of Etv2 to govern cell survival and vascular homeostasis via positive autoregulation. Pubmed 1.014E-11 3.808E-9 3.354E-8 3.808E-8 4 16
11 25117710 Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor. Pubmed 1.705E-11 5.818E-9 5.124E-8 6.400E-8 4 18
12 19829305 The mouse and human Fli1 genes are similarly regulated by Ets factors in T cells. Pubmed 2.370E-11 7.413E-9 6.529E-8 8.895E-8 3 3
13 20517297 Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo. Pubmed 9.476E-11 2.372E-8 2.089E-7 3.557E-7 3 4
14 22615925 The SAM domain of human TEL2 can abrogate transcriptional output from TEL1 (ETV-6) and ETS1/ETS2. Pubmed 9.476E-11 2.372E-8 2.089E-7 3.557E-7 3 4
15 12743594 EAPII interacts with ETS1 and modulates its transcriptional function. Pubmed 9.476E-11 2.372E-8 2.089E-7 3.557E-7 3 4
16 16263717 c-Myb and members of the c-Ets family of transcription factors act as molecular switches to mediate opposite steroid regulation of the human glucocorticoid receptor 1A promoter. Pubmed 2.369E-10 5.557E-8 4.895E-7 8.892E-7 3 5
17 11313879 c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells. Pubmed 4.736E-10 1.046E-7 9.212E-7 1.778E-6 3 6
18 16757682 Maturation stage-specific regulation of megakaryopoiesis by pointed-domain Ets proteins. Pubmed 1.326E-9 2.765E-7 2.435E-6 4.977E-6 3 8
19 17609113 A multipotent progenitor domain guides pancreatic organogenesis. Pubmed 1.115E-8 2.204E-6 1.941E-5 4.187E-5 4 85
20 8195215 An intricate arrangement of binding sites for the Ets family of transcription factors regulates activity of the alpha 4 integrin gene promoter. Pubmed 9.049E-8 8.286E-6 7.298E-5 3.397E-4 2 2
21 24277931 Transcription factor Ets1, but not the closely related factor Ets2, inhibits antibody-secreting cell differentiation. Pubmed 9.049E-8 8.286E-6 7.298E-5 3.397E-4 2 2
22 23926301 Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma. Pubmed 9.049E-8 8.286E-6 7.298E-5 3.397E-4 2 2
23 17986575 Transcriptional regulation of telomerase activity: roles of the the Ets transcription factor family. Pubmed 9.049E-8 8.286E-6 7.298E-5 3.397E-4 2 2
24 26093983 Mice Haploinsufficient for Ets1 and Fli1 Display Middle Ear Abnormalities and Model Aspects of Jacobsen Syndrome. Pubmed 9.049E-8 8.286E-6 7.298E-5 3.397E-4 2 2
25 16829517 Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program. Pubmed 9.049E-8 8.286E-6 7.298E-5 3.397E-4 2 2
26 8519813 The Ets family of proteins: weak modulators of gene expression in quest for transcriptional partners. Pubmed 9.049E-8 8.286E-6 7.298E-5 3.397E-4 2 2
27 2847145 Mammalian ets-1 and ets-2 genes encode highly conserved proteins. Pubmed 9.049E-8 8.286E-6 7.298E-5 3.397E-4 2 2
28 9651344 The ets family member Tel binds to the Fli-1 oncoprotein and inhibits its transcriptional activity. Pubmed 9.049E-8 8.286E-6 7.298E-5 3.397E-4 2 2
29 3285299 Characterization and localization of the products of the human homologs of the v-ets oncogene. Pubmed 9.049E-8 8.286E-6 7.298E-5 3.397E-4 2 2
30 11887334 In vivo modulation of ETS genes induced by electromagnetic fields. Pubmed 9.049E-8 8.286E-6 7.298E-5 3.397E-4 2 2
31 2044959 Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Pubmed 9.049E-8 8.286E-6 7.298E-5 3.397E-4 2 2
32 8183549 Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis. Pubmed 9.049E-8 8.286E-6 7.298E-5 3.397E-4 2 2
33 3019221 The avian and mammalian ets genes: molecular characterization, chromosome mapping, and implication in human leukemia. Pubmed 9.049E-8 8.286E-6 7.298E-5 3.397E-4 2 2
34 2997781 The ets sequence from the transforming gene of avian erythroblastosis virus, E26, has unique domains on human chromosomes 11 and 21: both loci are transcriptionally active. Pubmed 9.049E-8 8.286E-6 7.298E-5 3.397E-4 2 2
35 8474456 Both LyF-1 and an Ets protein interact with a critical promoter element in the murine terminal transferase gene. Pubmed 9.049E-8 8.286E-6 7.298E-5 3.397E-4 2 2
36 1511734 Ets-1 and Ets-2 protooncogene expression in theca cells of the adult mouse ovary. Pubmed 9.049E-8 8.286E-6 7.298E-5 3.397E-4 2 2
37 7851904 Mapping of the human SAP1 (SRF accessory protein 1) gene and SAP2, a gene encoding a related protein, to chromosomal bands 1q32 and 12q23, respectively. Pubmed 9.049E-8 8.286E-6 7.298E-5 3.397E-4 2 2
38 18958307 ETS-1 and ETS-2 are upregulated in a transgenic mouse model of pigmented ocular neoplasm. Pubmed 9.049E-8 8.286E-6 7.298E-5 3.397E-4 2 2
39 17077140 Expression of TEL-JAK2 in primary human hematopoietic cells drives erythropoietin-independent erythropoiesis and induces myelofibrosis in vivo. Pubmed 9.049E-8 8.286E-6 7.298E-5 3.397E-4 2 2
40 25595908 Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts. Pubmed 9.049E-8 8.286E-6 7.298E-5 3.397E-4 2 2
41 16930139 Transcription factor Fli-1 expression by bone marrow cells in chronic myeloproliferative disorders is independent of an underlying JAK2 (V617F) mutation. Pubmed 9.049E-8 8.286E-6 7.298E-5 3.397E-4 2 2
42 21989915 Analysis of gene networks in white adipose tissue development reveals a role for ETS2 in adipogenesis. Pubmed 2.714E-7 1.132E-5 9.972E-5 1.019E-3 2 3
43 17606295 Ets factors and a newly identified polymorphism regulate Fli1 promoter activity in lymphocytes. Pubmed 2.714E-7 1.132E-5 9.972E-5 1.019E-3 2 3
44 28859074 Open chromatin profiling identifies AP1 as a transcriptional regulator in oesophageal adenocarcinoma. Pubmed 2.714E-7 1.132E-5 9.972E-5 1.019E-3 2 3
45 9644975 Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway. Pubmed 2.714E-7 1.132E-5 9.972E-5 1.019E-3 2 3
46 25203538 Elk3 deficiency causes transient impairment in post-natal retinal vascular development and formation of tortuous arteries in adult murine retinae. Pubmed 2.714E-7 1.132E-5 9.972E-5 1.019E-3 2 3
47 11279115 Physical interaction and functional synergy between glucocorticoid receptor and Ets2 proteins for transcription activation of the rat cytochrome P-450c27 promoter. Pubmed 2.714E-7 1.132E-5 9.972E-5 1.019E-3 2 3
48 23774214 14-3-3 proteins modulate the ETS transcription factor ETV1 in prostate cancer. Pubmed 2.714E-7 1.132E-5 9.972E-5 1.019E-3 2 3
49 10377039 Transcription factors Ets1, Ets2, and Elf1 exhibit differential localization in human endometrium across the menstrual cycle and alternate isoforms in cultured endometrial cells. Pubmed 2.714E-7 1.132E-5 9.972E-5 1.019E-3 2 3
50 20554967 Ternary complex factors SAP-1 and Elk-1, but not net, are functionally equivalent in thymocyte development. Pubmed 2.714E-7 1.132E-5 9.972E-5 1.019E-3 2 3
Show 45 more annotations

9: Interaction [Display Chart] 12 input genes in category / 333 annotations before applied cutoff / 17703 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 int:SPI1 SPI1 interactions 5.398E-8 1.798E-5 1.148E-4 1.798E-5 4 59
2 int:COP1 COP1 interactions 3.727E-7 6.206E-5 3.963E-4 1.241E-4 4 95
3 int:JUN JUN interactions 9.090E-7 1.009E-4 6.444E-4 3.027E-4 5 296
4 int:TDP2 TDP2 interactions 3.553E-6 2.958E-4 1.889E-3 1.183E-3 3 46
5 int:MAPK8 MAPK8 interactions 9.351E-6 6.228E-4 3.977E-3 3.114E-3 4 213
6 int:STAT5B STAT5B interactions 2.198E-5 1.052E-3 6.721E-3 7.321E-3 3 84
7 int:MAPK3 MAPK3 interactions 2.344E-5 1.052E-3 6.721E-3 7.807E-3 4 269
8 int:SRF SRF interactions 2.528E-5 1.052E-3 6.721E-3 8.418E-3 3 88
9 int:ERG ERG interactions 3.820E-5 1.413E-3 9.027E-3 1.272E-2 3 101
10 int:CREBBP CREBBP interactions 1.080E-4 3.579E-3 2.286E-2 3.595E-2 4 398
11 int:FLI1 FLI1 interactions 1.253E-4 3.579E-3 2.286E-2 4.172E-2 2 25
12 int:NCOA3 NCOA3 interactions 1.290E-4 3.579E-3 2.286E-2 4.295E-2 3 152
13 int:DET1 DET1 interactions 1.937E-4 4.732E-3 3.022E-2
6.451E-2
 2 31
14 int:FOS FOS interactions 1.990E-4 4.732E-3 3.022E-2
6.625E-2
 3 176
15 int:UBE2I UBE2I interactions 2.152E-4 4.777E-3 3.051E-2
7.166E-2
 4 476
16 int:NCOR1 NCOR1 interactions 2.493E-4 5.188E-3 3.314E-2
8.301E-2
 3 190
17 int:GATA3 GATA3 interactions 2.921E-4 5.385E-3 3.439E-2
9.728E-2
 2 38
18 int:PRDM1 PRDM1 interactions 2.921E-4 5.385E-3 3.439E-2
9.728E-2
 2 38
19 int:KAT2B KAT2B interactions 3.072E-4 5.385E-3 3.439E-2
1.023E-1
 3 204
20 int:ETS2 ETS2 interactions 3.239E-4 5.393E-3 3.444E-2
1.079E-1
 2 40
21 int:ETV6 ETV6 interactions 3.404E-4 5.397E-3 3.447E-2
1.133E-1
 2 41
22 int:SRA1 SRA1 interactions 3.745E-4 5.669E-3 3.621E-2
1.247E-1
 2 43
23 int:MAPK14 MAPK14 interactions 7.122E-4 1.031E-2
6.585E-2
2.372E-1
 3 272
24 int:MAPK7 MAPK7 interactions 8.556E-4 1.187E-2
7.582E-2
2.849E-1
 2 65
25 int:ETS1 ETS1 interactions 9.088E-4 1.211E-2
7.731E-2
3.026E-1
 2 67
26 int:SOCS3 SOCS3 interactions 1.325E-3 1.674E-2
1.069E-1
4.411E-1
 2 81
27 int:SOCS1 SOCS1 interactions 1.357E-3 1.674E-2
1.069E-1
4.520E-1
 2 82
28 int:ID2 ID2 interactions 1.561E-3 1.857E-2
1.186E-1
5.198E-1
 2 88
29 int:GATA1 GATA1 interactions 1.970E-3 2.256E-2
1.441E-1
6.560E-1
 2 99
30 int:CHI3L2 CHI3L2 interactions 2.032E-3 2.256E-2
1.441E-1
6.768E-1
 1 3
31 int:SRC SRC interactions 2.242E-3 2.408E-2
1.538E-1
7.466E-1
 3 405
32 int:PDGFRB PDGFRB interactions 2.468E-3 2.568E-2
1.640E-1
8.219E-1
 2 111
33 int:NCOA1 NCOA1 interactions 2.691E-3 2.653E-2
1.695E-1
8.963E-1
 2 116
34 int:CRLF2 CRLF2 interactions 2.709E-3 2.653E-2
1.695E-1
9.021E-1
 1 4
35 int:EPAS1 EPAS1 interactions 2.972E-3 2.827E-2
1.806E-1
9.896E-1
 2 122
36 int:IL12RB2 IL12RB2 interactions 4.061E-3 3.559E-2
2.273E-1
1.000E0
 1 6
37 int:HES5 HES5 interactions 4.061E-3 3.559E-2
2.273E-1
1.000E0
 1 6
38 int:IL23R IL23R interactions 4.061E-3 3.559E-2
2.273E-1
1.000E0
 1 6
39 int:STK11 STK11 interactions 4.510E-3 3.755E-2
2.398E-1
1.000E0
 2 151
40 int:PIAS1 PIAS1 interactions 4.568E-3 3.755E-2
2.398E-1
1.000E0
 2 152
41 int:IL5RA IL5RA interactions 4.736E-3 3.755E-2
2.398E-1
1.000E0
 1 7
42 int:TMEM37 TMEM37 interactions 4.736E-3 3.755E-2
2.398E-1
1.000E0
 1 7
43 int:ARL11 ARL11 interactions 5.411E-3 4.095E-2
2.616E-1
1.000E0
 1 8
44 int:ETV7 ETV7 interactions 5.411E-3 4.095E-2
2.616E-1
1.000E0
 1 8
45 int:NKX2-1 NKX2-1 interactions 6.075E-3 4.312E-2
2.754E-1
1.000E0
 2 176
46 int:NCOA7 NCOA7 interactions 6.086E-3 4.312E-2
2.754E-1
1.000E0
 1 9
47 int:GABPB2 GABPB2 interactions 6.086E-3 4.312E-2
2.754E-1
1.000E0
 1 9
48 int:TWIST2 TWIST2 interactions 6.760E-3 4.595E-2
2.935E-1
1.000E0
 1 10
49 int:TBP TBP interactions 6.762E-3 4.595E-2
2.935E-1
1.000E0
 2 186
50 int:IFNGR2 IFNGR2 interactions 7.433E-3 4.736E-2
3.025E-1
1.000E0
 1 11
Show 45 more annotations

10: Cytoband [Display Chart] 12 input genes in category / 12 annotations before applied cutoff / 34661 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 11q24.1-q24.3 11q24.1-q24.3 3.462E-4 4.155E-3 1.289E-2 4.155E-3 1 1
2 12q23 12q23 2.421E-3 1.107E-2 3.434E-2 2.905E-2 1 7
3 9p24 9p24 2.767E-3 1.107E-2 3.434E-2 3.320E-2 1 8
4 19q13.3-q13.4 19q13.3-q13.4 4.492E-3 1.348E-2 4.182E-2
5.391E-2
 1 13
5 21q21.3 21q21.3 7.935E-3 1.904E-2
5.910E-2
9.522E-2
 1 23
6 7p21.3 7p21.3 9.996E-3 1.999E-2
6.204E-2
1.199E-1
 1 29
7 21q22.2 21q22.2 1.205E-2 2.066E-2
6.412E-2
1.446E-1
 1 35
8 1q32 1q32 1.684E-2 2.525E-2
7.837E-2
2.020E-1
 1 49
9 17q21 17q21 2.160E-2 2.714E-2
8.422E-2
2.592E-1
 1 63
10 12p13 12p13 2.262E-2 2.714E-2
8.422E-2
2.714E-1
 1 66
11 11q23.3 11q23.3 2.836E-2 3.094E-2
9.602E-2
3.404E-1
 1 83
Show 6 more annotations

11: Transcription Factor Binding Site [Display Chart] 12 input genes in category / 255 annotations before applied cutoff / 9770 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 CCCNNGGGAR V$OLF1 01 CCCNNGGGAR V$OLF1 01 2.020E-4 4.690E-2
2.870E-1
5.150E-2
 4 259
2 YYCATTCAWW UNKNOWN YYCATTCAWW UNKNOWN 8.201E-4 4.690E-2
2.870E-1
2.091E-1
 3 158
3 WYAAANNRNNNGCG UNKNOWN WYAAANNRNNNGCG UNKNOWN 1.389E-3 4.690E-2
2.870E-1
3.542E-1
 2 46
4 V$FREAC3 01 V$FREAC3 01 1.622E-3 4.690E-2
2.870E-1
4.136E-1
 3 200
5 V$PAX4 02 V$PAX4 02 1.622E-3 4.690E-2
2.870E-1
4.136E-1
 3 200
6 WGTTNNNNNAAA UNKNOWN WGTTNNNNNAAA UNKNOWN 1.636E-3 4.690E-2
2.870E-1
4.171E-1
 4 450
7 V$ETS1 B V$ETS1 B 1.693E-3 4.690E-2
2.870E-1
4.317E-1
 3 203
8 TTGCWCAAY V$CEBPB 02 TTGCWCAAY V$CEBPB 02 1.705E-3 4.690E-2
2.870E-1
4.349E-1
 2 51
9 V$NFAT Q4 01 V$NFAT Q4 01 1.996E-3 4.690E-2
2.870E-1
5.090E-1
 3 215
10 V$IK2 01 V$IK2 01 2.023E-3 4.690E-2
2.870E-1
5.159E-1
 3 216
11 V$HOXA4 Q2 V$HOXA4 Q2 2.023E-3 4.690E-2
2.870E-1
5.159E-1
 3 216
Show 6 more annotations

12: Gene Family [Display Chart] 12 input genes in category / 3 annotations before applied cutoff / 18194 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 534 ETS transcription factor family genenames.org 1.426E-31 4.277E-31 7.841E-31 4.277E-31 11 28
2 1293 Minor histocompatibility antigens|FERM domain containing genenames.org 3.249E-2 4.874E-2
8.936E-2
9.748E-2
 1 50

13: Coexpression [Display Chart] 12 input genes in category / 1760 annotations before applied cutoff / 23137 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 18689800-TableS6 Human EmbryonicStemCell Thomas08 113genes GeneSigDB 9.599E-12 1.689E-8 1.360E-7 1.689E-8 6 111
2 14993899-TableS1 Human Futreal04 427genes ConsensusCancerGenes GeneSigDB 1.242E-8 1.093E-5 8.796E-5 2.185E-5 6 364
3 M9150 Genes from common genomic gains observed in a meta analyis of copy number alterations across a panel of different cancer cell lines and tumor samples. MSigDB C2: CGP Curated Gene Sets (v6.0) 3.757E-7 2.204E-4 1.775E-3 6.613E-4 5 323
4 19286929-SuppTable2i Mouse Lung Rangasamy09 248genes GeneSigDB 1.269E-6 5.582E-4 4.494E-3 2.233E-3 4 168
5 15548366-Table2 Mouse Bladder Yao04 53genes GeneSigDB 1.819E-6 6.405E-4 5.156E-3 3.202E-3 3 48
6 M11064 Genes up-regulated in H358 cells (lung cancer) by inducible expression of CEBPA [GeneID=1050] off plasmid vector. MSigDB C2: CGP Curated Gene Sets (v6.0) 2.322E-6 6.812E-4 5.484E-3 4.087E-3 3 52
7 M11218 Examples of transcription factors whose activities are regulated by MAPK7 [GeneID=5598] phosphorylation. MSigDB C2: CGP Curated Gene Sets (v6.0) 6.893E-6 1.550E-3 1.248E-2 1.213E-2 2 8
8 16533764-Table3 Human Prostate Nadiminty06 110genes GeneSigDB 7.048E-6 1.550E-3 1.248E-2 1.240E-2 3 75
9 12429807-Table3 Human Viral Baran-Marszak02 26genes GeneSigDB 6.201E-5 1.108E-2
8.917E-2
1.091E-1
 2 23
10 18358739-Table1b Human LungNotCaner Kent08 28genes GeneSigDB 6.763E-5 1.108E-2
8.917E-2
1.190E-1
 2 24
11 14755241-Table2b Human Skin VanGele04 30genes GeneSigDB 1.064E-4 1.108E-2
8.917E-2
1.873E-1
 2 30
12 M19509 Down-regulated genes in the B lymphocyte developmental signature, based on expression profiling of lymphomas from the Emu-myc transgenic mice: plasma cell. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.290E-4 1.108E-2
8.917E-2
2.271E-1
 2 33
13 M4554 Genes down-regulated in comparison of thymic progenitors versus DN3 thymocytes. MSigDB C7: Immunologic Signatures (v6.0) 1.322E-4 1.108E-2
8.917E-2
2.326E-1
 3 200
14 M7491 Genes up-regulated in SELL dim [GeneID=6402] NK cells: NCAM1+ [GeneID=4684] versus NCAM1- [GeneID=4684]. MSigDB C7: Immunologic Signatures (v6.0) 1.322E-4 1.108E-2
8.917E-2
2.326E-1
 3 200
15 M6306 Genes up-regulated in control macrophages: untreated versus primed by IFNG [GeneID=3458]. MSigDB C7: Immunologic Signatures (v6.0) 1.322E-4 1.108E-2
8.917E-2
2.326E-1
 3 200
16 M9130 Genes down-regulated in T reg: IKZF4 [GeneID=64375] versus wildtype. MSigDB C7: Immunologic Signatures (v6.0) 1.322E-4 1.108E-2
8.917E-2
2.326E-1
 3 200
17 M5271 Genes down-regulated in comparison of type 2 myeloid (T2M) cells treated with IL25 [GeneID=64806] versus eosinophils treated with IL25 [GeneID=64806]. MSigDB C7: Immunologic Signatures (v6.0) 1.322E-4 1.108E-2
8.917E-2
2.326E-1
 3 200
18 M9735 Genes down-regulated in CD4 [GeneID=920] SMARTA memory T cells: Th1 versus follicular helper (Tfh). MSigDB C7: Immunologic Signatures (v6.0) 1.322E-4 1.108E-2
8.917E-2
2.326E-1
 3 200
19 M4407 Genes down-regulated in comparison of naive CD8 T cells versus naive CD4 [GeneID=920] CD8 T cells. MSigDB C7: Immunologic Signatures (v6.0) 1.322E-4 1.108E-2
8.917E-2
2.326E-1
 3 200
20 M5600 Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells versus those treated with IL1B [GeneID=3553] and IL6 [GeneID=3569]. MSigDB C7: Immunologic Signatures (v6.0) 1.322E-4 1.108E-2
8.917E-2
2.326E-1
 3 200
21 M5953 Genes up-regulated by KRAS activation. MSigDB H: Hallmark Gene Sets (v6.0) 1.322E-4 1.108E-2
8.917E-2
2.326E-1
 3 200
22 M1476 B lymphocyte early differentiation genes (EDG): top genes down-regulated in tonsil B lymphocytes (TBC) compared to the tonsil plasma cells (TPC). MSigDB C2: CGP Curated Gene Sets (v6.0) 2.099E-4 1.679E-2
1.352E-1
3.694E-1
 2 42
23 17571080-SuppTable2b Human Leukemia Sun07 283genes GeneSigDB 2.291E-4 1.753E-2
1.411E-1
4.032E-1
 3 241
24 M847 Genes up-regulated in group C of tumors arising from overexpression of BCL2L1 and MYC [GeneID=598;4609] in plasma cells. MSigDB C2: CGP Curated Gene Sets (v6.0) 2.631E-4 1.930E-2
1.553E-1
4.631E-1
 2 47
25 12393520-Table2 Human Bone Marrow Zhan03 50genes earlyDiff GeneSigDB 2.861E-4 2.014E-2
1.621E-1
5.035E-1
 2 49
26 16533764-Table1 Human Prostate Nadiminty06 50genes UpRegulated GeneSigDB 2.979E-4 2.017E-2
1.624E-1
5.243E-1
 2 50
27 15466190-Table1 Human StemCell Moreno04 62genes GeneSigDB 3.606E-4 2.307E-2
1.857E-1
6.347E-1
 2 55
28 M2886 Genes up-regulated in epithelial lung and breast cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene. MSigDB C6: Oncogenic Signatures (v6.0) 3.671E-4 2.307E-2
1.857E-1
6.460E-1
 3 283
29 12531789-TableS1b Human Viral Klein03 67genes GeneSigDB 3.874E-4 2.351E-2
1.893E-1
6.818E-1
 2 57
30 M18825 Genes down-regulated in AIDS-related primary effusion lymphoma (PEL) samples compared to other tumor subtypes and normal B lymphocytes. MSigDB C2: CGP Curated Gene Sets (v6.0) 4.011E-4 2.353E-2
1.894E-1
7.059E-1
 2 58
31 M7030 Genes down-regulated in MCF7 cells (breast cancer) treated with hypoxia mimetic DMOG [PubChem=3080614]. MSigDB C2: CGP Curated Gene Sets (v6.0) 4.150E-4 2.356E-2
1.897E-1
7.305E-1
 2 59
32 M7899 Oxidative stress genes down-regulated in ARPE-19 cells (retinal pigmented epithelium) in response to HNE and tBH [PubChem=5283344;6410]. MSigDB C2: CGP Curated Gene Sets (v6.0) 4.292E-4 2.361E-2
1.901E-1
7.554E-1
 2 60
33 M6752 Genes essential to the development of megakaryocytes, as expressed in normal cells and essential thrombocythemic cells (ET). MSigDB C2: CGP Curated Gene Sets (v6.0) 5.193E-4 2.611E-2
2.102E-1
9.139E-1
 2 66
34 15459216-TableA2b Human Leukemia Haslinger04 75genes GeneSigDB 5.193E-4 2.611E-2
2.102E-1
9.139E-1
 2 66
35 M12353 Genes up-regulated in papillary thyroid carcinoma (PTC) compared to other thyroid tumors. MSigDB C2: CGP Curated Gene Sets (v6.0) 5.193E-4 2.611E-2
2.102E-1
9.139E-1
 2 66
36 M5370 Genes down-regulated in follicular thyroid adenoma (FTA) compared to other thyroid tumors. MSigDB C2: CGP Curated Gene Sets (v6.0) 5.512E-4 2.695E-2
2.169E-1
9.700E-1
 2 68
37 M2504 Genes whose expression changes in Calu-6 cells (lung cancer) by TNF [GeneID=7124] were not affected by p38 inhibitor LY479754. MSigDB C2: CGP Curated Gene Sets (v6.0) 6.111E-4 2.861E-2
2.303E-1
1.000E0
 3 337
38 16423987-SuppTable3d Human Leukemia Erkeland06 199genes GeneSigDB 6.177E-4 2.861E-2
2.303E-1
1.000E0
 2 72
39 M17471 Genes up-regulated in invasive ductal carcinoma (IDC) relative to ductal carcinoma in situ (DCIS, non-invasive). MSigDB C2: CGP Curated Gene Sets (v6.0) 6.879E-4 3.027E-2
2.437E-1
1.000E0
 3 351
40 19377508-SuppTable2 Human Lymphoma Chin09 110genes GeneSigDB 6.880E-4 3.027E-2
2.437E-1
1.000E0
 2 76
41 M1604 Genes up-regulated in MEF cells (embryonic fibroblast) upon Cre-lox knockout of DNMT1 [GeneID=1786]. MSigDB C2: CGP Curated Gene Sets (v6.0) 7.061E-4 3.031E-2
2.440E-1
1.000E0
 2 77
42 18435859-Table1 Mouse Breast Piechocki08 140genes GeneSigDB 7.245E-4 3.036E-2
2.444E-1
1.000E0
 2 78
43 M2339 Direct targets of PRDM5 [GeneID=11107]. MSigDB C2: CGP Curated Gene Sets (v6.0) 7.431E-4 3.041E-2
2.449E-1
1.000E0
 2 79
44 18768393-Table1 Human Viral Rodriguez-Caballero09 98genes GeneSigDB 8.003E-4 3.135E-2
2.524E-1
1.000E0
 2 82
45 M4735 Genes up-regulated in MCF7 cells (breast cancer) engineered to conditionally express LMO4 [GeneID=8543] by a Tet Off system. MSigDB C2: CGP Curated Gene Sets (v6.0) 8.017E-4 3.135E-2
2.524E-1
1.000E0
 3 370
46 15466190-TableS3 Human StemCell Moreno04 101genes GeneSigDB 8.395E-4 3.212E-2
2.586E-1
1.000E0
 2 84
47 16135802-Table1 Human Pancreas Levy05 114genes GeneSigDB 9.002E-4 3.371E-2
2.714E-1
1.000E0
 2 87
48 M17083 Up-regulated genes in the B lymphocyte developmental signature, based on expression profiling of lymphomas from the Emu-myc transgenic mice: the mature B MSigDB C2: CGP Curated Gene Sets (v6.0) 9.629E-4 3.531E-2
2.842E-1
1.000E0
 2 90
49 19755675-TableS6 Human Leukemia Li09 419genes GeneSigDB 1.079E-3 3.875E-2
3.120E-1
1.000E0
 3 410
50 M3654 Genes up-regulated in samples with systolic heart failure compared to normal hearts. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.173E-3 3.885E-2
3.127E-1
1.000E0
 3 422
Show 45 more annotations

14: Coexpression Atlas [Display Chart] 12 input genes in category / 1312 annotations before applied cutoff / 21829 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 gudmap dev gonad e12.5 F gudmap devVasOvary Flk k4 200 dev gonad e12.5 F DevVasOvary Flk k-means-cluster#4 top-relative-expression-ranked 200 Gudmap Mouse ST 1.0 1.191E-7 1.562E-4 1.212E-3 1.562E-4 4 88
2 Kidney10XCellRanger Six2KI E14 Endo Endo Subtype E14-Six2KI-Endo-C13-KC2 Top 200 Genes Kidney10XCellRanger Six2KI E14 Endo Endo Subtype E14-Six2KI-Endo-C13-KC2 Top 200 Genes 5.990E-7 3.044E-4 2.361E-3 7.859E-4 5 335
3 gudmap dev gonad e12.5 M gudmap devVasTestis Flk k2 200 dev gonad e12.5 M DevVasTestis Flk k-means-cluster#2 top-relative-expression-ranked 200 Gudmap Mouse ST 1.0 1.188E-6 3.044E-4 2.361E-3 1.559E-3 4 156
4 gudmap dev gonad e12.5 F gudmap devVasOvary Flk 200 dev gonad e12.5 F DevVasOvary Flk top-relative-expression-ranked 200 Gudmap Mouse ST 1.0 1.922E-6 3.044E-4 2.361E-3 2.522E-3 4 176
5 gudmap dev gonad e13.5 F gudmap devVascOvary Flk 200 dev gonad e13.5 F DevVascOvary Flk top-relative-expression-ranked 200 Gudmap Mouse ST 1.0 2.056E-6 3.044E-4 2.361E-3 2.697E-3 4 179
6 gudmap dev gonad e12.5 M gudmap devVasTestis Flk 200 dev gonad e12.5 M DevVasTestis Flk top-relative-expression-ranked 200 Gudmap Mouse ST 1.0 2.102E-6 3.044E-4 2.361E-3 2.758E-3 4 180
7 gudmap dev gonad e11.5 M ReproVasc Flk 200 dev gonad e11.5 M ReproVasc Flk top-relative-expression-ranked 200 Gudmap Mouse ST 1.0 2.197E-6 3.044E-4 2.361E-3 2.882E-3 4 182
8 Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Heart/endothelial cell Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Heart/endothelial cell Tabula Muris Consortium 2.245E-6 3.044E-4 2.361E-3 2.945E-3 4 183
9 Kidney10XCellRanger Six2KI E14 Endo Endo Overall Top 200 Genes Kidney10XCellRanger Six2KI E14 Endo Endo Overall Top 200 Genes 2.344E-6 3.044E-4 2.361E-3 3.076E-3 4 185
10 Kidney10XCellRanger Six2KI E14 Endo Endo Subtype E14-Six2KI-Endo-C13-KC8 Top 200 Genes Kidney10XCellRanger Six2KI E14 Endo Endo Subtype E14-Six2KI-Endo-C13-KC8 Top 200 Genes 2.447E-6 3.044E-4 2.361E-3 3.210E-3 4 187
11 Kidney10XCellRanger Six2KI P0 Endo Endo Overall Top 200 Genes Kidney10XCellRanger Six2KI P0 Endo Endo Overall Top 200 Genes 2.552E-6 3.044E-4 2.361E-3 3.349E-3 4 189
12 Kidney10XCellRanger Six2KI P0 Endo Endo Subtype P0-Six2KI-Endo-C4-KC8 Top 200 Genes Kidney10XCellRanger Six2KI P0 Endo Endo Subtype P0-Six2KI-Endo-C4-KC8 Top 200 Genes 3.260E-6 3.564E-4 2.765E-3 4.277E-3 4 201
13 Kidney10XCellRanger Six2KI P0 Endo Endo Subtype P0-Six2KI-Endo-C6-KC8 Top 200 Genes Kidney10XCellRanger Six2KI P0 Endo Endo Subtype P0-Six2KI-Endo-C6-KC8 Top 200 Genes 3.663E-6 3.567E-4 2.767E-3 4.806E-3 4 207
14 Lungmap Lungmap - Mouse FluidigmC1 Endothelial Endothelial Subtype endothelial cells B PND07-28 Top 200 Genes Lungmap Lungmap - Mouse FluidigmC1 Endothelial Endothelial Subtype endothelial cells B PND07-28 Top 200 Genes 3.806E-6 3.567E-4 2.767E-3 4.993E-3 4 209
15 gudmap dev gonad e11.5 M ReproVasc Flk k3 500 dev gonad e11.5 M ReproVasc Flk k-means-cluster#3 top-relative-expression-ranked 500 Gudmap Mouse ST 1.0 5.189E-6 4.539E-4 3.521E-3 6.808E-3 4 226
16 Kidney10XCellRanger Six2KI P0 Endo Endo Subtype P0-Six2KI-Endo-C7-KC8 Top 200 Genes Kidney10XCellRanger Six2KI P0 Endo Endo Subtype P0-Six2KI-Endo-C7-KC8 Top 200 Genes 9.448E-6 7.748E-4 6.010E-3 1.240E-2 4 263
17 gudmap dev gonad e13.5 M gudmap devVasTestis Flk k4 500 dev gonad e13.5 M DevVasTestis Flk k-means-cluster#4 top-relative-expression-ranked 500 Gudmap Mouse ST 1.0 1.244E-5 9.227E-4 7.158E-3 1.632E-2 4 282
18 Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Mammary Gland/endothelial cell Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Mammary Gland/endothelial cell Tabula Muris Consortium 1.266E-5 9.227E-4 7.158E-3 1.661E-2 3 86
19 Kidney10XCellRanger Six2KI P0 Endo Endo Top 200 Kidney10XCellRanger Six2KI P0 Endo Endo Top 200 1.427E-5 9.412E-4 7.301E-3 1.872E-2 4 292
20 gudmap dev gonad e12.5 M gudmap devVasTestis Flk k2 500 dev gonad e12.5 M DevVasTestis Flk k-means-cluster#2 top-relative-expression-ranked 500 Gudmap Mouse ST 1.0 1.546E-5 9.412E-4 7.301E-3 2.028E-2 4 298
21 Kidney10XCellRanger Six2KI E14 Endo Endo Subtype E14-Six2KI-Endo-C13-KC1 Top 200 Genes Kidney10XCellRanger Six2KI E14 Endo Endo Subtype E14-Six2KI-Endo-C13-KC1 Top 200 Genes 1.546E-5 9.412E-4 7.301E-3 2.028E-2 4 298
22 gudmap kidney e10.5 UretericTrunk HoxB7 k3 1000 kidney e10.5 UretericTrunk HoxB7 k-means-cluster#3 top-relative-expression-ranked 1000 Gudmap Mouse MOE430.2 1.602E-5 9.412E-4 7.301E-3 2.101E-2 3 93
23 gudmap developingKidney e15.5 Endothelial cells 1000 k1 DevelopingKidney e15.5 Endothelial cells emap-29965 k-means-cluster#1 top-relative-expression-ranked 1000 Gudmap Mouse MOE430.2 1.650E-5 9.412E-4 7.301E-3 2.165E-2 4 303
24 Kidney10XCellRanger Six2KI E14 Endo Endo Subtype E14-Six2KI-Endo-C13-KC4 Top 200 Genes Kidney10XCellRanger Six2KI E14 Endo Endo Subtype E14-Six2KI-Endo-C13-KC4 Top 200 Genes 2.070E-5 1.131E-3 8.777E-3 2.716E-2 4 321
25 gudmap dev gonad e13.5 F gudmap devVascOvary Flk k2 200 dev gonad e13.5 F DevVascOvary Flk k-means-cluster#2 top-relative-expression-ranked 200 Gudmap Mouse ST 1.0 2.650E-5 1.391E-3 1.079E-2 3.477E-2 3 110
26 gudmap dev gonad e11.5 F ReproVasc Flk k3 200 dev gonad e11.5 F ReproVasc Flk k-means-cluster#3 top-relative-expression-ranked 200 Gudmap Mouse ST 1.0 3.106E-5 1.568E-3 1.216E-2 4.076E-2 3 116
27 gudmap kidney adult GlomCapSys Tie2 k4 500 kidney adult GlomCapSys Tie2 k-means-cluster#4 top-relative-expression-ranked 500 Gudmap Mouse MOE430.2 5.105E-5 2.241E-3 1.738E-2
6.697E-2
 3 137
28 gudmap dev gonad e11.5 F ReproVasc Flk 500 dev gonad e11.5 F ReproVasc Flk top-relative-expression-ranked 500 Gudmap Mouse ST 1.0 5.336E-5 2.241E-3 1.738E-2
7.001E-2
 4 409
29 gudmap kidney e15.5 SmlBldVes Tie2 500 kidney e15.5 SmlBldVes Tie2 top-relative-expression-ranked 500 Gudmap Mouse MOE430.2 5.542E-5 2.241E-3 1.738E-2
7.272E-2
 4 413
30 gudmap dev gonad e11.5 M ReproVasc Flk 500 dev gonad e11.5 M ReproVasc Flk top-relative-expression-ranked 500 Gudmap Mouse ST 1.0 5.595E-5 2.241E-3 1.738E-2
7.340E-2
 4 414
31 gudmap dev gonad e12.5 M gudmap devVasTestis Flk 500 dev gonad e12.5 M DevVasTestis Flk top-relative-expression-ranked 500 Gudmap Mouse ST 1.0 5.595E-5 2.241E-3 1.738E-2
7.340E-2
 4 414
32 gudmap dev gonad e12.5 F gudmap devVasOvary Flk 500 dev gonad e12.5 F DevVasOvary Flk top-relative-expression-ranked 500 Gudmap Mouse ST 1.0 5.648E-5 2.241E-3 1.738E-2
7.410E-2
 4 415
33 gudmap dev gonad e13.5 F gudmap devVascOvary Flk 500 dev gonad e13.5 F DevVascOvary Flk top-relative-expression-ranked 500 Gudmap Mouse ST 1.0 5.701E-5 2.241E-3 1.738E-2
7.479E-2
 4 416
34 Lungmap Lungmap - Mouse FluidigmC1 Endothelial Endothelial Top 200 Lungmap Lungmap - Mouse FluidigmC1 Endothelial Endothelial Top 200 5.808E-5 2.241E-3 1.738E-2
7.620E-2
 4 418
35 gudmap dev gonad e13.5 M gudmap devVasTestis Flk 500 dev gonad e13.5 M DevVasTestis Flk top-relative-expression-ranked 500 Gudmap Mouse ST 1.0 6.484E-5 2.363E-3 1.833E-2
8.507E-2
 4 430
36 DevelopingKidney e15.5 Endothelial cells emap-29977 k5 1000 DevelopingKidney e15.5 Endothelial cells emap-29977 k-means-cluster#5 top-relative-expression-ranked 1000 Gudmap Mouse MOE430.2 6.484E-5 2.363E-3 1.833E-2
8.507E-2
 4 430
37 gudmap dev gonad e11.5 F ReproVasc Flk k3 1000 dev gonad e11.5 F ReproVasc Flk k-means-cluster#3 top-relative-expression-ranked 1000 Gudmap Mouse ST 1.0 7.343E-5 2.604E-3 2.020E-2
9.634E-2
 4 444
38 Lung Development Lungmap - Mouse FluidigmC1 Endothelial Overall Top 500 Genes Lung Development Lungmap - Mouse FluidigmC1 Endothelial Overall Top 500 Genes 8.283E-5 2.860E-3 2.218E-2
1.087E-1
 4 458
39 gudmap dev gonad e13.5 F gudmap devVascOvary Flk k3 500 dev gonad e13.5 F DevVascOvary Flk k-means-cluster#3 top-relative-expression-ranked 500 Gudmap Mouse ST 1.0 9.695E-5 3.262E-3 2.530E-2
1.272E-1
 3 170
40 Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Diaphrag/lymphocyte Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Diaphrag/lymphocyte Tabula Muris Consortium 1.093E-4 3.516E-3 2.728E-2
1.434E-1
 3 177
41 Lungmap Lungmap - Mouse FluidigmC1 Endothelial Endothelial Overall Top 200 Genes Lungmap Lungmap - Mouse FluidigmC1 Endothelial Endothelial Overall Top 200 Genes 1.148E-4 3.516E-3 2.728E-2
1.507E-1
 3 180
42 gudmap dev gonad e11.5 F ReproVasc Flk 200 dev gonad e11.5 F ReproVasc Flk top-relative-expression-ranked 200 Gudmap Mouse ST 1.0 1.187E-4 3.516E-3 2.728E-2
1.557E-1
 3 182
43 Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Aorta/endothelial cell Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Aorta/endothelial cell Tabula Muris Consortium 1.206E-4 3.516E-3 2.728E-2
1.582E-1
 3 183
44 Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Pancreas/endothelial cell Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Pancreas/endothelial cell Tabula Muris Consortium 1.206E-4 3.516E-3 2.728E-2
1.582E-1
 3 183
45 Kidney10XCellRanger Six2TGC TSC1 P0 Endo Endo Overall Top 200 Genes Kidney10XCellRanger Six2TGC TSC1 P0 Endo Endo Overall Top 200 Genes 1.206E-4 3.516E-3 2.728E-2
1.582E-1
 3 183
46 Kidney10XCellRanger Six2TGC TSC1 P0 Endo Endo Subtype P0-Six2TGC Tsc1-Endo-C8-KC6 Top 200 Genes Kidney10XCellRanger Six2TGC TSC1 P0 Endo Endo Subtype P0-Six2TGC Tsc1-Endo-C8-KC6 Top 200 Genes 1.266E-4 3.570E-3 2.769E-2
1.660E-1
 3 186
47 Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Fat/B cell Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Fat/B cell Tabula Muris Consortium 1.286E-4 3.570E-3 2.769E-2
1.687E-1
 3 187
48 Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Fat/endothelial cell Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Fat/endothelial cell Tabula Muris Consortium 1.306E-4 3.570E-3 2.769E-2
1.714E-1
 3 188
49 gudmap kidney e15.5 SmlBldVes Tie2 k4 500 kidney e15.5 SmlBldVes Tie2 k-means-cluster#4 top-relative-expression-ranked 500 Gudmap Mouse MOE430.2 1.348E-4 3.609E-3 2.799E-2
1.768E-1
 3 190
50 Lungmap Lungmap - Mouse FluidigmC1 Endothelial Endothelial Subtype endothelial cells B Top 200 Genes Lungmap Lungmap - Mouse FluidigmC1 Endothelial Endothelial Subtype endothelial cells B Top 200 Genes 1.390E-4 3.648E-3 2.829E-2
1.824E-1
 3 192
Show 45 more annotations

15: Computational [Display Chart] 11 input genes in category / 40 annotations before applied cutoff / 10037 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 M13751 MODULE 123 Genes in the cancer module 123. MSigDb: C4 - CM: Cancer Modules (v6.0) 1.031E-4 4.123E-3 1.764E-2 4.123E-3 4 247
2 M4082 MODULE 234 Bone remodeling. MSigDb: C4 - CM: Cancer Modules (v6.0) 1.515E-3 3.030E-2
1.296E-1
6.059E-2
 2 54

16: MicroRNA [Display Chart] 12 input genes in category / 603 annotations before applied cutoff / 72241 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 hsa-miR-193b-3p:TargetScan hsa-miR-193b-3p TargetScan 3.438E-8 1.036E-5 7.234E-5 2.073E-5 4 211
2 hsa-miR-193a-3p:TargetScan hsa-miR-193a-3p TargetScan 3.438E-8 1.036E-5 7.234E-5 2.073E-5 4 211
3 hsa-miR-410-3p:TargetScan hsa-miR-410-3p TargetScan 5.955E-7 1.094E-4 7.637E-4 3.591E-4 4 431
4 hsa-miR-598:mirSVR lowEffct hsa-miR-598:mirSVR nonconserved lowEffect-0.1-0.5 MicroRNA.org 7.258E-7 1.094E-4 7.637E-4 4.377E-4 4 453
5 hsa-miR-193a-3p:PITA hsa-miR-193a-3p:PITA TOP PITA 1.649E-6 1.692E-4 1.181E-3 9.944E-4 3 143
6 hsa-miR-193b:PITA hsa-miR-193b:PITA TOP PITA 1.684E-6 1.692E-4 1.181E-3 1.015E-3 3 144
7 hsa-miR-371a-5p:TargetScan hsa-miR-371a-5p TargetScan 1.170E-5 8.723E-4 6.089E-3 7.057E-3 3 275
8 hsa-miR-365a-3p:TargetScan hsa-miR-365a-3p TargetScan 1.302E-5 8.723E-4 6.089E-3 7.851E-3 3 285
9 hsa-miR-365b-3p:TargetScan hsa-miR-365b-3p TargetScan 1.302E-5 8.723E-4 6.089E-3 7.851E-3 3 285
10 hsa-miR-335-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.594E-5 9.611E-4 6.708E-3 9.611E-3 3 305
11 hsa-miR-3163:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 2.242E-5 1.193E-3 8.327E-3 1.352E-2 3 342
12 hsa-miR-222-3p:TargetScan hsa-miR-222-3p TargetScan 2.972E-5 1.193E-3 8.327E-3 1.792E-2 3 376
13 hsa-miR-221-3p:TargetScan hsa-miR-221-3p TargetScan 2.972E-5 1.193E-3 8.327E-3 1.792E-2 3 376
14 GTCAGGA,MIR-378:MSigDB GTCAGGA,MIR-378:MSigDB MSigDB 3.085E-5 1.193E-3 8.327E-3 1.860E-2 2 50
15 hsa-miR-155-5p:TargetScan hsa-miR-155-5p TargetScan 3.238E-5 1.193E-3 8.327E-3 1.952E-2 3 387
16 hsa-miR-204-5p:Functional MTI Functional MTI miRTarbase 3.545E-5 1.193E-3 8.327E-3 2.138E-2 3 399
17 hsa-miR-122*:mirSVR lowEffct hsa-miR-122*:mirSVR nonconserved lowEffect-0.1-0.5 MicroRNA.org 3.956E-5 1.193E-3 8.327E-3 2.385E-2 3 414
18 hsa-miR-199a-5p:TargetScan hsa-miR-199a-5p TargetScan 4.187E-5 1.193E-3 8.327E-3 2.525E-2 3 422
19 hsa-miR-199b-5p:TargetScan hsa-miR-199b-5p TargetScan 4.187E-5 1.193E-3 8.327E-3 2.525E-2 3 422
20 hsa-miR-142-3p.2:TargetScan hsa-miR-142-3p.2 TargetScan 4.397E-5 1.193E-3 8.327E-3 2.651E-2 3 429
21 CAGTATT,MIR-200B:MSigDB CAGTATT,MIR-200B:MSigDB MSigDB 4.550E-5 1.193E-3 8.327E-3 2.744E-2 3 434
22 CAGTATT,MIR-429:MSigDB CAGTATT,MIR-429:MSigDB MSigDB 4.550E-5 1.193E-3 8.327E-3 2.744E-2 3 434
23 CAGTATT,MIR-200C:MSigDB CAGTATT,MIR-200C:MSigDB MSigDB 4.550E-5 1.193E-3 8.327E-3 2.744E-2 3 434
24 hsa-miR-654-3p:Functional MTI Functional MTI miRTarbase 6.070E-5 1.525E-3 1.065E-2 3.660E-2 2 70
25 GGCCAGT,MIR-193B:MSigDB GGCCAGT,MIR-193B:MSigDB MSigDB 9.173E-5 2.128E-3 1.485E-2
5.532E-2
 2 86
26 GGCCAGT,MIR-193A:MSigDB GGCCAGT,MIR-193A:MSigDB MSigDB 9.173E-5 2.128E-3 1.485E-2
5.532E-2
 2 86
27 GGGCATT,MIR-365:MSigDB GGGCATT,MIR-365:MSigDB MSigDB 1.342E-4 2.997E-3 2.092E-2
8.092E-2
 2 104
28 hsa-miR-4422:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.556E-4 3.352E-3 2.340E-2
9.385E-2
 2 112
29 hsa-miR-526a:PITA hsa-miR-526a:PITA TOP PITA 1.877E-4 3.429E-3 2.394E-2
1.132E-1
 2 123
30 hsa-miR-519b-5p:PITA hsa-miR-519b-5p:PITA TOP PITA 1.877E-4 3.429E-3 2.394E-2
1.132E-1
 2 123
31 hsa-miR-518d-5p:PITA hsa-miR-518d-5p:PITA TOP PITA 1.877E-4 3.429E-3 2.394E-2
1.132E-1
 2 123
32 hsa-miR-520c-5p:PITA hsa-miR-520c-5p:PITA TOP PITA 1.877E-4 3.429E-3 2.394E-2
1.132E-1
 2 123
33 hsa-miR-519c-5p:PITA hsa-miR-519c-5p:PITA TOP PITA 1.877E-4 3.429E-3 2.394E-2
1.132E-1
 2 123
34 hsa-miR-328:PITA hsa-miR-328:PITA TOP PITA 1.969E-4 3.457E-3 2.413E-2
1.187E-1
 2 126
35 ATGTAGC,MIR-222:MSigDB ATGTAGC,MIR-222:MSigDB MSigDB 2.064E-4 3.457E-3 2.413E-2
1.245E-1
 2 129
36 ATGTAGC,MIR-221:MSigDB ATGTAGC,MIR-221:MSigDB MSigDB 2.064E-4 3.457E-3 2.413E-2
1.245E-1
 2 129
37 hsa-miR-1291:PITA hsa-miR-1291:PITA TOP PITA 2.128E-4 3.469E-3 2.421E-2
1.283E-1
 2 131
38 TTGGAGA,MIR-519E:MSigDB TTGGAGA,MIR-519E:MSigDB MSigDB 2.260E-4 3.494E-3 2.439E-2
1.363E-1
 2 135
39 TTGGAGA,MIR-515-5P:MSigDB TTGGAGA,MIR-515-5P:MSigDB MSigDB 2.260E-4 3.494E-3 2.439E-2
1.363E-1
 2 135
40 hsa-miR-4262:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 2.395E-4 3.611E-3 2.521E-2
1.444E-1
 2 139
41 hsa-miR-758:PITA hsa-miR-758:PITA TOP PITA 2.976E-4 4.378E-3 3.056E-2
1.795E-1
 2 155
42 hsa-miR-532-3p:PITA hsa-miR-532-3p:PITA TOP PITA 3.053E-4 4.384E-3 3.060E-2
1.841E-1
 2 157
43 hsa-miR-1202:PITA hsa-miR-1202:PITA TOP PITA 3.131E-4 4.391E-3 3.065E-2
1.888E-1
 2 159
44 hsa-miR-1248:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 3.290E-4 4.473E-3 3.122E-2
1.984E-1
 2 163
45 hsa-miR-1260:PITA hsa-miR-1260:PITA TOP PITA 3.371E-4 4.473E-3 3.122E-2
2.033E-1
 2 165
46 hsa-miR-199a-5p:Non-Functional MTI Non-Functional MTI miRTarbase 3.412E-4 4.473E-3 3.122E-2
2.057E-1
 2 166
47 hsa-miR-548as-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 3.704E-4 4.707E-3 3.286E-2
2.234E-1
 2 173
48 GCAAAAA,MIR-129:MSigDB GCAAAAA,MIR-129:MSigDB MSigDB 3.747E-4 4.707E-3 3.286E-2
2.259E-1
 2 174
49 hsa-miR-208a:mirSVR highEffct hsa-miR-208a:mirSVR conserved highEffect-0.5 MicroRNA.org 3.964E-4 4.878E-3 3.405E-2
2.390E-1
 2 179
50 hsa-miR-758-3p:TargetScan hsa-miR-758-3p TargetScan 4.097E-4 4.942E-3 3.449E-2
2.471E-1
 2 182
Show 45 more annotations

17: Drug [Display Chart] 12 input genes in category / 4598 annotations before applied cutoff / 22841 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 CID000003154 Cosopt Stitch 3.100E-17 1.426E-13 1.285E-12 1.426E-13 10 341
2 CID000448972 1uyf Stitch 1.824E-8 4.194E-5 3.779E-4 8.389E-5 4 58
3 CID000448959 AC1L9MJT Stitch 3.008E-8 4.610E-5 4.154E-4 1.383E-4 5 192
4 CID000208772 A-skin Stitch 5.448E-7 6.263E-4 5.643E-3 2.505E-3 3 32
5 CID003054237 EF-T Stitch 1.351E-6 9.083E-4 8.185E-3 6.213E-3 3 43
6 7091 DN ICI182,780; Down 200; 1uM; MCF7; HT HG-U133A Broad Institute CMAP Down 2.090E-6 9.083E-4 8.185E-3 9.609E-3 4 188
7 5088 DN Pyrantel tartrate [33401-94-4]; Down 200; 11.2uM; PC3; HT HG-U133A Broad Institute CMAP Down 2.320E-6 9.083E-4 8.185E-3 1.067E-2 4 193
8 4341 DN Vincamine [1617-90-9]; Down 200; 11.2uM; PC3; HT HG-U133A Broad Institute CMAP Down 2.368E-6 9.083E-4 8.185E-3 1.089E-2 4 194
9 6873 DN H-89, Dihydrochloride; Down 200; 0.5uM; PC3; HT HG-U133A Broad Institute CMAP Down 2.467E-6 9.083E-4 8.185E-3 1.134E-2 4 196
10 5072 DN Pizotifen malate [5189-11-7]; Down 200; 9.4uM; PC3; HT HG-U133A Broad Institute CMAP Down 2.517E-6 9.083E-4 8.185E-3 1.157E-2 4 197
11 4091 DN Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; PC3; HT HG-U133A Broad Institute CMAP Down 2.517E-6 9.083E-4 8.185E-3 1.157E-2 4 197
12 4214 DN Propantheline bromide [50-34-0]; Down 200; 9uM; PC3; HT HG-U133A Broad Institute CMAP Down 2.568E-6 9.083E-4 8.185E-3 1.181E-2 4 198
13 4496 UP Pindolol [13523-86-9]; Up 200; 16.2uM; PC3; HT HG-U133A Broad Institute CMAP Up 2.568E-6 9.083E-4 8.185E-3 1.181E-2 4 198
14 CID000407233 X 48 Stitch 1.388E-5 4.559E-3 4.108E-2
6.382E-2
 2 11
15 ctd:C506614 PD 0325901 CTD 2.578E-5 6.440E-3
5.803E-2
1.185E-1
 3 114
16 CID000165609 4,4-dimethylzymosterol Stitch 3.853E-5 6.440E-3
5.803E-2
1.772E-1
 2 18
17 CID000005307 A19413 Stitch 3.906E-5 6.440E-3
5.803E-2
1.796E-1
 3 131
18 CID000005291 imatinib Stitch 5.439E-5 6.440E-3
5.803E-2
2.501E-1
 4 430
19 ctd:C100075 mibolerone CTD 6.939E-5 6.440E-3
5.803E-2
3.190E-1
 2 24
20 CID000286683 NSC145391 Stitch 6.954E-5 6.440E-3
5.803E-2
3.197E-1
 3 159
21 5260 DN Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT HG-U133A Broad Institute CMAP Down 8.482E-5 6.440E-3
5.803E-2
3.900E-1
 3 170
22 1637 DN Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT HG-U133A Broad Institute CMAP Down 8.782E-5 6.440E-3
5.803E-2
4.038E-1
 3 172
23 2330 DN Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT HG-U133A Broad Institute CMAP Down 8.782E-5 6.440E-3
5.803E-2
4.038E-1
 3 172
24 4590 UP Etilefrine hydrochloride [534-87-2]; Up 200; 18.4uM; PC3; HT HG-U133A Broad Institute CMAP Up 9.561E-5 6.440E-3
5.803E-2
4.396E-1
 3 177
25 4495 UP (-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; PC3; HT HG-U133A Broad Institute CMAP Up 9.561E-5 6.440E-3
5.803E-2
4.396E-1
 3 177
26 1672 DN Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT HG-U133A Broad Institute CMAP Down 9.722E-5 6.440E-3
5.803E-2
4.470E-1
 3 178
27 4641 UP GBR 12909 dihydrochloride [67469-78-7]; Up 200; 7.6uM; PC3; HT HG-U133A Broad Institute CMAP Up 1.005E-4 6.440E-3
5.803E-2
4.621E-1
 3 180
28 2620 DN Amoxicillin [26787-78-0]; Down 200; 11uM; MCF7; HT HG-U133A Broad Institute CMAP Down 1.090E-4 6.440E-3
5.803E-2
5.011E-1
 3 185
29 CID000001633 SU4984 Stitch 1.092E-4 6.440E-3
5.803E-2
5.020E-1
 2 30
30 3819 DN Withaferin A [5119-48-2]; Down 200; 1uM; PC3; HT HG-U133A Broad Institute CMAP Down 1.107E-4 6.440E-3
5.803E-2
5.092E-1
 3 186
31 1656 DN 15d-PGJ2; Down 200; 10uM; MCF7; HT HG-U133A Broad Institute CMAP Down 1.125E-4 6.440E-3
5.803E-2
5.173E-1
 3 187
32 6997 DN ICI 182,780; Down 200; 0.01uM; MCF7; HT HG-U133A Broad Institute CMAP Down 1.161E-4 6.440E-3
5.803E-2
5.339E-1
 3 189
33 5084 DN Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT HG-U133A Broad Institute CMAP Down 1.179E-4 6.440E-3
5.803E-2
5.423E-1
 3 190
34 7145 UP Nocodazole [31430-18-9]; Up 200; 13.2uM; PC3; HT HG-U133A Broad Institute CMAP Up 1.179E-4 6.440E-3
5.803E-2
5.423E-1
 3 190
35 1019 DN LY 294002; Down 200; 10uM; MCF7; HT HG-U133A EA Broad Institute CMAP Down 1.179E-4 6.440E-3
5.803E-2
5.423E-1
 3 190
36 3966 DN 0317956-0000 [391210-11-0]; Down 200; 10uM; MCF7; HT HG-U133A Broad Institute CMAP Down 1.198E-4 6.440E-3
5.803E-2
5.508E-1
 3 191
37 5118 UP Deptropine citrate [2169-75-7]; Up 200; 7.6uM; PC3; HT HG-U133A Broad Institute CMAP Up 1.217E-4 6.440E-3
5.803E-2
5.594E-1
 3 192
38 4288 DN PNU-0230031 [267429-39-0]; Down 200; 10uM; PC3; HT HG-U133A Broad Institute CMAP Down 1.217E-4 6.440E-3
5.803E-2
5.594E-1
 3 192
39 3753 DN Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT HG-U133A Broad Institute CMAP Down 1.217E-4 6.440E-3
5.803E-2
5.594E-1
 3 192
40 6714 DN Hesperidin [520-26-3]; Down 200; 6.6uM; PC3; HT HG-U133A Broad Institute CMAP Down 1.217E-4 6.440E-3
5.803E-2
5.594E-1
 3 192
41 4477 UP 6-Furfurylaminopurine [525-79-1]; Up 200; 18.6uM; PC3; HT HG-U133A Broad Institute CMAP Up 1.235E-4 6.440E-3
5.803E-2
5.680E-1
 3 193
42 4537 UP Orphenadrine hydrochloride [341-69-5]; Up 200; 13uM; PC3; HT HG-U133A Broad Institute CMAP Up 1.254E-4 6.440E-3
5.803E-2
5.768E-1
 3 194
43 4474 UP Sulfanilamide [63-74-1]; Up 200; 23.2uM; PC3; HT HG-U133A Broad Institute CMAP Up 1.254E-4 6.440E-3
5.803E-2
5.768E-1
 3 194
44 2467 DN Omeprazole [73590-58-6]; Down 200; 11.6uM; HL60; HT HG-U133A Broad Institute CMAP Down 1.254E-4 6.440E-3
5.803E-2
5.768E-1
 3 194
45 4221 DN Tolnaftate [2398-96-1]; Down 200; 13uM; PC3; HT HG-U133A Broad Institute CMAP Down 1.254E-4 6.440E-3
5.803E-2
5.768E-1
 3 194
46 5813 UP Pyridoxine hydrochloride [58-56-0]; Up 200; 19.4uM; PC3; HT HG-U133A Broad Institute CMAP Up 1.274E-4 6.440E-3
5.803E-2
5.856E-1
 3 195
47 4224 DN Benzocaine [94-09-7]; Down 200; 24.2uM; PC3; HT HG-U133A Broad Institute CMAP Down 1.274E-4 6.440E-3
5.803E-2
5.856E-1
 3 195
48 3812 DN Diethylstilbestrol [56-53-1]; Down 200; 15uM; PC3; HT HG-U133A Broad Institute CMAP Down 1.274E-4 6.440E-3
5.803E-2
5.856E-1
 3 195
49 6522 DN Azapropazone [13539-59-8]; Down 200; 13.4uM; MCF7; HT HG-U133A Broad Institute CMAP Down 1.274E-4 6.440E-3
5.803E-2
5.856E-1
 3 195
50 6662 UP Fluspirilen [1841-19-6]; Up 200; 8.4uM; PC3; HT HG-U133A Broad Institute CMAP Up 1.274E-4 6.440E-3
5.803E-2
5.856E-1
 3 195
Show 45 more annotations

18: Disease [Display Chart] 12 input genes in category / 712 annotations before applied cutoff / 16205 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 C0005699 Blast Phase DisGeNET Curated 1.372E-5 3.575E-3 2.555E-2 9.770E-3 4 215
2 C0085669 Acute leukemia DisGeNET Curated 1.661E-5 3.575E-3 2.555E-2 1.183E-2 5 491
3 C0678128 Friend leukemia DisGeNET BeFree 1.804E-5 3.575E-3 2.555E-2 1.285E-2 2 9
4 C1540912 Hypereosinophilic syndrome DisGeNET Curated 3.304E-5 3.575E-3 2.555E-2 2.353E-2 2 12
5 C0263662 Disseminated eosinophilic collagen disease DisGeNET BeFree 3.304E-5 3.575E-3 2.555E-2 2.353E-2 2 12
6 C1857230 DISORGANIZATION, MOUSE, HOMOLOG OF DisGeNET BeFree 3.304E-5 3.575E-3 2.555E-2 2.353E-2 2 12
7 C0026987 Myelofibrosis DisGeNET Curated 3.515E-5 3.575E-3 2.555E-2 2.503E-2 3 90
8 C0795841 Jacobsen Distal 11q Deletion Syndrome DisGeNET Curated 4.552E-5 4.010E-3 2.865E-2 3.241E-2 2 14
9 C0040034 Thrombocytopenia DisGeNET Curated 5.069E-5 4.010E-3 2.865E-2 3.609E-2 4 300
10 C0392386 Decreased platelet count DisGeNET Curated 6.757E-5 4.811E-3 3.438E-2 4.811E-2 3 112
11 C0404521 Infective vaginitis DisGeNET BeFree 7.641E-5 4.822E-3 3.446E-2
5.440E-2
 2 18
12 C0023462 Acute Megakaryocytic Leukemias DisGeNET Curated 8.716E-5 4.822E-3 3.446E-2
6.206E-2
 3 122
13 C0553580 Ewings sarcoma DisGeNET Curated 9.437E-5 4.822E-3 3.446E-2
6.719E-2
 4 352
14 C0006852 Candidiasis of vagina DisGeNET BeFree 9.481E-5 4.822E-3 3.446E-2
6.750E-2
 2 20
15 OMIN:601626 LEUKEMIA, ACUTE MYELOID; AML OMIM 1.375E-4 6.526E-3 4.664E-2
9.789E-2
 2 24
16 C0001815 Primary Myelofibrosis DisGeNET Curated 2.056E-4 7.306E-3
5.221E-2
1.464E-1
 3 163
17 C0279583 T-cell childhood acute lymphoblastic leukemia DisGeNET BeFree 2.162E-4 7.306E-3
5.221E-2
1.539E-1
 2 30
18 C0153381 Malignant neoplasm of mouth DisGeNET BeFree 2.174E-4 7.306E-3
5.221E-2
1.548E-1
 4 437
19 C0220641 Lip and Oral Cavity Carcinoma DisGeNET BeFree 2.232E-4 7.306E-3
5.221E-2
1.589E-1
 4 440
20 C0745091 Hypereosinophilia DisGeNET BeFree 2.310E-4 7.306E-3
5.221E-2
1.645E-1
 2 31
21 C0206141 Idiopathic Hypereosinophilic Syndrome DisGeNET BeFree 2.463E-4 7.306E-3
5.221E-2
1.753E-1
 2 32
22 C1802398 Chromosome 5, trisomy 5q DisGeNET BeFree 2.463E-4 7.306E-3
5.221E-2
1.753E-1
 2 32
23 C0085702 Monocytosis DisGeNET Curated 2.463E-4 7.306E-3
5.221E-2
1.753E-1
 2 32
24 C1853195 Prostate Cancer, Hereditary, 7 DisGeNET Curated 2.463E-4 7.306E-3
5.221E-2
1.753E-1
 2 32
25 C1292779 Myelodysplastic Syndrome with Isolated del(5q) DisGeNET BeFree 2.621E-4 7.339E-3
5.245E-2
1.866E-1
 2 33
26 C0016781 Fuchs Endothelial Dystrophy DisGeNET Curated 2.783E-4 7.339E-3
5.245E-2
1.982E-1
 2 34
27 C1847319 PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA DisGeNET Curated 2.783E-4 7.339E-3
5.245E-2
1.982E-1
 2 34
28 C0376634 Craniofacial Abnormalities DisGeNET Curated 2.891E-4 7.353E-3
5.254E-2
2.059E-1
 3 183
29 C0740302 5q-syndrome DisGeNET Curated 3.123E-4 7.545E-3
5.392E-2
2.224E-1
 2 36
30 C0376544 Hematopoietic Neoplasms DisGeNET BeFree 3.179E-4 7.545E-3
5.392E-2
2.263E-1
 3 189
31 C0346421 Chronic eosinophilic leukemia DisGeNET Curated 3.300E-4 7.579E-3
5.416E-2
2.350E-1
 2 37
32 C0023448 Lymphoid leukemia DisGeNET Curated 3.484E-4 7.753E-3
5.540E-2
2.481E-1
 3 195
33 C0014591 Epistaxis DisGeNET Curated 4.463E-4 9.451E-3
6.754E-2
3.178E-1
 2 43
34 C0041107 Trisomy DisGeNET Curated 4.513E-4 9.451E-3
6.754E-2
3.213E-1
 3 213
35 C0023440 Acute Erythroblastic Leukemia DisGeNET Curated 4.960E-4 1.009E-2
7.211E-2
3.532E-1
 3 220
36 C1292778 Chronic myeloproliferative disorder DisGeNET BeFree 6.013E-4 1.014E-2
7.246E-2
4.281E-1
 3 235
37 C0272138 Erythroblastosis DisGeNET BeFree 6.038E-4 1.014E-2
7.246E-2
4.299E-1
 2 50
38 C2939461 Myeloid neoplasm DisGeNET BeFree 6.038E-4 1.014E-2
7.246E-2
4.299E-1
 2 50
39 C1838656 Macrocytosis, Familial DisGeNET Curated 7.405E-4 1.014E-2
7.246E-2
5.272E-1
 1 1
40 C0431111 Rhabdomyosarcoma with ganglionic differentiation DisGeNET BeFree 7.405E-4 1.014E-2
7.246E-2
5.272E-1
 1 1
41 C1956093 Paris-Trousseau Thrombocytopenia DisGeNET Curated 7.405E-4 1.014E-2
7.246E-2
5.272E-1
 1 1
42 C0235969 Disorder of ejaculation DisGeNET BeFree 7.405E-4 1.014E-2
7.246E-2
5.272E-1
 1 1
43 20090331:Kilpivaara Myeloproliferative neoplasms GWAS 7.405E-4 1.014E-2
7.246E-2
5.272E-1
 1 1
44 C4015537 THROMBOCYTOPENIA 5 DisGeNET Curated 7.405E-4 1.014E-2
7.246E-2
5.272E-1
 1 1
45 OMIN:263300 POLYCYTHEMIA VERA OMIM 7.405E-4 1.014E-2
7.246E-2
5.272E-1
 1 1
46 cv:CN225711 Thrombocytopenia 5 Clinical Variations 7.405E-4 1.014E-2
7.246E-2
5.272E-1
 1 1
47 C1112443 Male sexual dysfunction DisGeNET BeFree 7.405E-4 1.014E-2
7.246E-2
5.272E-1
 1 1
48 C1328061 Myelodysplastic/myeloproliferative neoplasm, unclassifiable DisGeNET BeFree 7.405E-4 1.014E-2
7.246E-2
5.272E-1
 1 1
49 C0002890 Leukoerythroblastic Anemia DisGeNET BeFree 7.405E-4 1.014E-2
7.246E-2
5.272E-1
 1 1
50 cv:C0032463 Polycythemia vera Clinical Variations 7.405E-4 1.014E-2
7.246E-2
5.272E-1
 1 1
Show 45 more annotations